Genetic Technologies Limited announced the appointment of Simon Morriss to the role of Chief Executive Officer, commencing on 1 February 2021. Simon brings over 20 years' experience within the Pharmaceutical, Healthcare and FMCG industries having held senior executive positions at Sanofi and Blackmores. He brings a wealth of experience in managing teams and successfully executing across sales, marketing and brand building. Additionally, Key highlights critical in leading commercialisation across these industries and understands the unique pressures and opportunities. Simon has led companies through strategic adaptation to execution and will be driving Genetic Technologies commercialisation strategy and continue to drive innovation across the business. Additionally, the Board announced that George Muchnicki, who has been Acting CEO since September 2019, will be stepping into the role of Chief Medical Officer and Executive Director.